Deep Tech Startups

Cascade is building modern ground-station infrastructure to provide deep space communication capacity for commercial space missions, using arrays of smaller dishes rather than single large antennas. It aims to offer an alternative to the oversubscribed Deep Space Network, with new capacity planned to come online in 2027.

5 investors

CellVoyant is an AI-first company that develops predictive analytics and optimization tools for cell-based therapeutic development, helping researchers accelerate process development and reduce costs through label-free imaging analysis and data-driven process optimization.

5 investors

Cerevance is a clinical-stage drug discovery and development company developing non-dopaminergic, orally-delivered therapies for brain and central nervous system disorders, including Parkinson's disease, schizophrenia, Alzheimer's disease, and ALS. It uses a proprietary human brain tissue profiling platform (NETSseq) and advances candidates such as solengepras (CVN424), CVN293, and CVN766 through clinical trials.

5 investors

CheMastery builds a chemistry-agnostic software and hardware platform that automates and standardizes organic chemistry workflows, connecting R&D and manufacturing through robotic synthesis, purification, and reaction monitoring. It serves chemical research and manufacturing operations of all sizes across applications ranging from drug discovery to advanced materials.

5 investors

ClearMotion develops active suspension systems for automotive vehicles. The company manufactures production-ready suspension technology with a focus on serving the automotive industry.

5 investors

ClearSpace develops in-orbit servicing technologies for satellite disposal, inspection, and life-extension, serving both institutional and commercial space missions. Founded in Switzerland and headquartered in Luxembourg, it works with agencies such as ESA on active debris removal and satellite life-extension missions across Europe.

5 investors

Cognitive3D provides an analytics platform for XR (VR/AR) applications, capturing user behavior, app activity, and device inputs to let teams replay and analyze sessions in full 3D. It offers session records, participant profiles, 3D replays with gaze and movement visualization, and data export/integration for teams building and evaluating XR experiences.

5 investors

Copernic develops catalysts for zero-carbon ammonia and e-fuels that are cost-competitive and compatible with existing industrial infrastructure. The company uses scientific computing to improve heterogeneous catalyst design for the chemical industry.

5 investors

CorInnova develops a minimally invasive, non-blood contacting cardiac assist device designed to treat acute heart failure patients who cannot use existing solutions. The collapsible device is delivered via minimally invasive procedures and compresses the heart externally to increase cardiac output without the risks of blood clotting, stroke, or anticoagulation-related complications.

5 investors

Cornelis provides high-performance networking solutions for artificial intelligence and high-performance computing applications serving enterprise, cloud service providers, supercomputing centers, government labs, and research institutions. The company offers the Omni-Path fabric platform with software libraries designed to accelerate AI model training, scientific computing, and complex simulations.

5 investors

CTGT develops a governance layer for AI systems that enables direct intervention at the neural network representation level to ensure reliable, policy-aligned AI behavior for enterprises. The company targets organizations that need to deploy AI responsibly with built-in accountability and control mechanisms.

5 investors

Dewpoint Therapeutics develops condensate-modulating drugs by using an integrated platform that maps, measures, and modulates biomolecular condensates to identify druggable targets and disease mechanisms. Its discovery engine combines biology, chemistry, proprietary datasets, and AI to pursue therapies for complex diseases, including previously undruggable targets.

5 investors

DigiLens develops waveguide optics and holographic display technology using a proprietary material set combined with inkjet printing and a holographic contact copy process. Its optics target efficiency, brightness, and resolution for augmented reality and next-generation mobile computing devices.

5 investors

Dioxycle develops electricity-driven technology to convert waste carbon emissions into chemical feedstocks for industrial manufacturing. The company serves chemical manufacturers seeking to reduce fossil fuel dependence and production costs through electrochemical recycling of CO2.

5 investors

Draig Therapeutics is a clinical-stage biotech company developing neuromodulator therapies for neuropsychiatric disorders such as major depressive disorder. Its lead program, DT-101, is a Phase 2 AMPA receptor potentiator, and it is also advancing selective GABAA receptor modulators.

5 investors

DUDE CHEM develops computational chemistry and digitalization tools for sustainable chemical manufacturing, using green chemistry principles to reduce waste and hazardous substances in the production of chemicals, starting materials, and pharmaceutical ingredients (APIs).

5 investors

Eden GeoPower develops an Electrical Reservoir Stimulation technology intended to improve the recovery of natural resources with reduced environmental impact. The company targets applications supporting the transition to carbon neutrality.

5 investors

Emerge is building a multi-sensory communication platform that uses a tabletop device generating an ultrasonic forcefield to let users feel on-screen content in their bare hands without controllers or gloves. Powered by Emotion AI, it aims to add touch, sight, sound, and shared tactile experiences to at-home communication across VR, AR, and smart TVs.

5 investors

Endurance Energy develops subsea geothermal technology to generate renewable electricity from volcanic activity on the seafloor, providing reliable 24/7 power with minimal environmental footprint for islands, industrial sites, and data centers.

5 investors

Enhanced Radar develops aviation-grade AI training datasets for pilot-controller communications, with end-to-end quality control from data collection through labeling. The company serves aviation safety and efficiency applications.

5 investors

Epic Aerospace builds Orbit Transfer Vehicles (space tugs) that enable satellites to be deployed to any orbital destination from shared launch vehicles and to move within space. The company provides infrastructure and end-to-end support services for satellite missions.

5 investors

Everix manufactures ultra-thin plastic optical filters designed to match the performance of traditional glass filters in systems with compact geometries, SWaP-C requirements, and non-flat or free-form optical surfaces. The filters serve optical device and system designers across multiple industries.

5 investors

EVQLV develops a computational platform for antibody discovery that uses machine learning and computational biology to accelerate and reduce the cost of generating fully-human antibodies for drug development. The platform serves pharmaceutical and biotech partners working on antibody therapeutics.

5 investors

EX-Fusion is a Japanese private company developing laser-based nuclear fusion energy technology, aiming to decarbonize existing energy sources and contribute to carbon neutrality. It also develops advanced optical control technology derived from its fusion research to build new light-based industries.

5 investors